Effect of pharmacological therapies for stroke prevention on major gastrointestinal bleeding in patients with atrial fibrillation.
about
Economic evaluation of warfarin, dabigatran, rivaroxaban, and apixaban for stroke prevention in atrial fibrillationCosts of major intracranial, gastrointestinal and other bleeding events in patients with atrial fibrillation - a nationwide cohort study.Gastrointestinal comorbidities associated with atrial fibrillation.The safety and efficacy of vitamin K antagonist in atrial fibrillation patients with previous ulcer bleeding: Long-term results from a multicenter study.Risk of Gastrointestinal Bleeding Among Dabigatran Users - A Self Controlled Case Series Analysis.Benefit-risk assessment of dabigatran in the treatment of stroke prevention in non-valvular atrial fibrillation.The risk of gastrointestinal bleeding in patients receiving dabigatran etexilate: a systematic review and meta-analysis of the literature.Risk of gastrointestinal bleeding during anticoagulant treatment.Effectiveness and safety of vitamin K antagonists and new anticoagulants in the prevention of thromboembolism in atrial fibrillation in older adults - a systematic review of reviews and the development of recommendations to reduce inappropriate presEffectiveness and patient safety of platelet aggregation inhibitors in the prevention of cardiovascular disease and ischemic stroke in older adults - a systematic review.Gastrointestinal haemorrhage in atrial fibrillation patients: impact of quality of anticoagulation control.Characteristics and predictors for gastrointestinal hemorrhage among adult patients with dengue virus infection: Emphasizing the impact of existing comorbid disease(s).Aspirin Has a Protective Effect Against Adverse Outcomes in Patients with Nonvariceal Upper Gastrointestinal Bleeding.Resuming anticoagulants after anticoagulation-associated intracranial haemorrhage: systematic review and meta-analysis.
P2860
Q33651588-30800410-1F71-4C00-B01D-1B31F91280CBQ33791638-84B2BA71-938D-41E9-91DA-679E6FC95437Q34409701-55695FFD-CDB3-4E68-8F64-D95950F692A5Q37468281-1BBBDD2E-6A22-4350-8109-C92334571767Q37595293-40FAFAF7-62A5-4B26-B4E8-1C6AA1CF0C2DQ38200587-282B976F-9C91-4E92-8AD8-022E169A5244Q39022742-5D5A6629-4CE1-40B8-955A-10BD0C0B9F5DQ39280394-196F1384-EA7E-4D85-9A1B-AE5C1E3653D1Q42676634-DA6EEEE9-A7A6-46B0-8509-F9C9D71EDE5BQ42676674-B4AAB98A-82B5-4735-A080-CD815182E8D2Q48021946-77B78655-D3DD-43CC-971B-ADA4A749E341Q52692686-0E35AD8E-B36F-48DA-A9A2-88DFC29ED371Q53597262-370CB196-C276-4717-A44B-B58FC65149B0Q55354315-7212D8C6-5148-4B0E-A72C-77C5C7910089
P2860
Effect of pharmacological therapies for stroke prevention on major gastrointestinal bleeding in patients with atrial fibrillation.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Effect of pharmacological ther ...... ents with atrial fibrillation.
@ast
Effect of pharmacological ther ...... ents with atrial fibrillation.
@en
Effect of pharmacological ther ...... ents with atrial fibrillation.
@nl
type
label
Effect of pharmacological ther ...... ents with atrial fibrillation.
@ast
Effect of pharmacological ther ...... ents with atrial fibrillation.
@en
Effect of pharmacological ther ...... ents with atrial fibrillation.
@nl
prefLabel
Effect of pharmacological ther ...... ents with atrial fibrillation.
@ast
Effect of pharmacological ther ...... ents with atrial fibrillation.
@en
Effect of pharmacological ther ...... ents with atrial fibrillation.
@nl
P2093
P2860
P1476
Effect of pharmacological ther ...... ents with atrial fibrillation.
@en
P2093
C I Coleman
D M Sobieraj
M Mediouni
S Alikhanov
P2860
P356
10.1111/J.1742-1241.2011.02809.X
P577
2011-10-31T00:00:00Z